Topamax

Topamax is the most common such drug I encounter in my patient population.

Thoughts on the Contraceptive Patch and Blood Clot Risks aka TBTAM 2008

The drug is sold under the brand name Topamax by Johnson & Johnson and is also available in generic versions.

FDA Strengthens Topamax Warning Thomas Gryta 2011

Topiramate is sold under the brand name Topamax by Johnson & Johnson to treat migraines and seizures.

FDA Rejects Vivus's Obesity Drug Qnexa Jennifer Corbett Dooren 2010

Earlier this month, the Food and Drug Administration strengthened warnings that expectant mothers who take topiramate brand name Topamax, for migraines or to control seizures, have an increased risk of giving birth to babies with cleft lips or cleft palates.

Can Mom's Medicine Hurt the Baby? Melinda Beck 2011

Topiramate is sold under the brand name Topamax by

FDA Finds 'Significant' Weight Loss With Qnexa 2010

Half received treatment with the drug topiramate, an anti-convulsant sold under the brand name Topamax, while the other half received a placebo.

Epilepsy Drug Helps Alcoholics Quit the Bottle | Impact Lab 2007

Researchers, led by Bankole Johnson, chairman of the Department of Psychiatric Medicine at the University of Virginia in Charlottesville, have been studying whether topiramate, sold under the brand name Topamax by a unit of Johnson & Johnson, might treat alcoholism.

Drug to Treat Migraines May Help 2007

There's a new one out called Topamax, again for people out there who have migraines.

CNN Transcript Dec 4, 2003 2003

Ortho-McNeil agreed to pay $50.7 million to settle allegations that it engaged in off-label marketing of its drug Topamax, which is approved by the U.S.

Philadelphia Business News - Local Philadelphia News | The Philadelphia Business Journal 2010

The drug, used to control weight, combines relatively low doses of the generic stimulant phentermine and epilepsy drug topiramate (sold under the brand name Topamax) in a capsule designed to release the components timed to minimize side effects.

GuruFocus Updates - 2009